Dr. Fizza Khalid | Microbiology Award | Best Researcher Award

Dr. Fizza Khalid | Microbiology Award | Best Researcher Award 

Dr. Fizza Khalid, Dr Sulaiman Al-Habib Medical Diagnostic Laboratory, Saudi Arabia

Fizza Khalid is a dedicated Microbiologist with a robust educational background and extensive experience in laboratory research and clinical analysis. She holds a Ph.D. in Medical Microbiology from the University of Health Sciences in Lahore, where her research focused on the characterization of drug-resistant Acinetobacter baumannii strains. With a solid foundation in both M.Phil. and M.Sc. degrees in Medical Microbiology and Medical Technology, respectively, Fizza has developed expertise in microbial resistance and quality control in clinical settings. Currently serving as the Deputy Head of the Clinical Research Committee and Specialized Lab Supervisor at MD LAB, Dr. Sulaiman AlHabib Medical Group in Saudi Arabia, she excels in collaborative research, training healthcare professionals, and ensuring compliance with regulatory standards. Fizza is committed to advancing microbiological science and improving patient outcomes through her meticulous approach and passion for research, making her a valuable asset to any healthcare organization.

Professional Profile:

ORCID 

Summary of Suitability for Best Researcher Award:

Dr. Fizza Khalid is an exemplary candidate for the Best Researcher Award, distinguished by her extensive educational background and significant contributions to the field of microbiology. With a Ph.D. in Medical Microbiology from the University of Health Sciences, her research has primarily focused on the characterization of drug-resistant strains of Acinetobacter baumannii, a critical issue in healthcare today.

Education:

  • Ph.D. in Medical Microbiology
    University of Health Sciences, Lahore (2016–2023)
    Thesis: Characterization of locally isolated Acinetobacter baumannii strains for drug resistance and biofilm formation.
  • M. Phil in Medical Microbiology
    University of Health Sciences, Lahore (2012–2014)
    Thesis: In-vitro efficacy of Polymyxin B with Rifampin, Colistin, and Doxycycline against extensively drug-resistant Acinetobacter baumannii.
  • M.Sc. in Medical Technology
    University of Health Sciences, Lahore (2008–2010)
    Thesis: Frequency of extended spectrum beta-lactamase enzymes in the clinical isolate of Salmonella typhi.
  • B.Sc. in Medical Laboratory Technology
    University of the Health Sciences, Lahore (2005–2007).

Work Experience:

  • Deputy Head of Clinical Research Committee/Specialized Lab Supervisor Microbiology
    MD LAB, Dr. Sulaiman AlHabib Medical Group, KSA (September 2023 – Present)

    • Collaborate with scientists and healthcare professionals.
    • Ensure compliance with regulatory agencies (CAP, CBAHI, JCI).
    • Conduct research and write manuscripts for publication.
    • Prepare and present data at international conferences.
    • Facilitate junior researchers and promote clinical research culture through workshops.
    • Train healthcare professionals in study design and scientific writing.
    • Maintain laboratory records and prepare reports.
    • Train and supervise laboratory personnel.
  • Senior Lab Technologist
    Dr. Sulaiman AlHabib Medical Group, KSA (January 2017 – February 2022)

    • Review, revise, and create standard operating protocols for the Clinical Microbiology Lab.
    • Perform laboratory analysis of clinical specimens and interpret results.
    • Monitor accuracy and quality of clinical microbiology testing.
    • Ensure compliance with safety regulations and quality control standards.

Publication top Notes:

Molecular epidemiology and antimicrobial resistance features of Acinetobacter baumannii clinical isolates from Pakistan

High prevalence of carbapenem-resistant Acinetobacter baumannii associated respiratory tract infections in Pakistani hospitals.

A Cyclic-di-GMP signalling network regulates biofilm formation and surface associated motility of Acinetobacter baumannii 17978

Methylglyoxal: Antimicrobial activity against blood culture isolates of Salmonella Typhi and other Gram negative rods.

In-vitro efficacy of polymyxin B with rifampin, colistin and doxycycline against extensively drug resistant Acinetobacter baumannii